Dudediligence.

Embecta Corp

EMBCNASDAQ · Surgical & Medical Instruments & Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$286.1MSep ’24$261.9MDec ’24$259.0MMar ’25$295.5MJun ’25$264.0MSep ’25$261.2MDec ’25$221.8MMar ’26$271.7MJun ’26
Net income, by quarter
$14.6MSep ’24$0.00Dec ’24$23.5MMar ’25$45.5MJun ’25$26.4MSep ’25$44.1MDec ’25−$4.1MMar ’26$21.1MJun ’26
Fiscal years, by the month each ended
LineSep 2021Sep 2022Sep 2023Sep 2024Sep 2025
Revenue$1.17B$1.13B$1.12B$1.12B$1.08B
Gross profit$800.4M$774.9M$749.9M$735.2M$676.8M
Operating income$492.0M$309.6M$221.5M$166.8M$242.1M
Net income$414.8M$223.6M$70.4M$78.3M$95.4M
Operating cash flow$456.3M$412.2M$67.7M$35.7M$191.7M
Free cash flow$419.5M$388.6M$41.2M$19.9M$182.4M
Cash$0.00$330.9M$326.3M$267.5M$225.5M
Debt$0.00$1.61B$1.60B$1.57B$1.40B
Shares outstanding57.0M57.1M57.3M57.7M58.5M